About UsShanghai Tenghu biological Technology Co., Ltd In 2012, with rapid development of Chinese vacutainer industry. Shanghai Tenghu biological Technology Co., Ltd. was established. Tenghu introduced advanced scientific research institutions, rely on the product advantages of internationalization and high starting point, the company has begun to expand the domestic and foreign markets, endeavor to provide customers with high quality vacutainer additive products and Customer service.Through the company's unremitting pursuit of high quality and product innovation, a high specification technology R & D center was established in Shanghai, equipped with advanced inspection and testing equipment. At the same time,Tengben was in close cooperation with several research institutions, a joint R & D laboratory was established to make the products of Tenghu reach a new professional height. In 2018, advanced separation gel synthesis technology, vacutainer's coagulant main composition thrombin constant temperature preservation technology and so on core technology, it provides technical guarantee for Tenghu participation in global competition, withstood the long-term inspection of global markets. Through the research and accumulation of these ten years, Tenghu, has grown from a single vacutainer additives to provide customers with a vacutainer integrated system with a complete set of vacuum vessel production equipment, laboratory consumables and additives."Professional build the height, focus achieve the quality" is Tenghu's concept which always been adhering, based on this concept, Tenghu has passed ISO9001:2015 certificate, the core technology products have applied for national patents. Professionalism and focus make us not only produce high quality products, but also stand at the forefront of the industry and win the trust and support of global customers.
Country / Region
China
Province
Shanghai
Business Type
Manufacturer
Main Products
Serum Separation Gel, Blood Clot Activator, blood collection tube production line, PRP gel, anticoagulant filling machine
Year Established
2020
Employees
5 - 10 People
Turnover One Year
US$2.5 Million - US$5 Million
Main Markets
Domestic Market: 57%
South America: 9%
South Asia: 7%